{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
US Previously Marketed
Source:
21 CFR 310.545(a)(8)(ii) digestive aid bean
Source URL:
First approved in 2021
Source:
21 CFR 349
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125814
(2024)
Source URL:
First approved in 2021
Source:
BLA125741
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
YENAYA SECRET GUNG CLEANSER by IFACKOREA CO., LTD
(2021)
Source URL:
First approved in 2021
Source:
YENAYA SECRET GUNG CLEANSER by IFACKOREA CO., LTD
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
Strengthening Basil Root by Topiderm, Inc
(2021)
Source URL:
First approved in 2021
Source:
Strengthening Basil Root by Topiderm, Inc
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125740
(2021)
Source URL:
First approved in 2021
Source:
BLA125740
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125685
(2021)
Source URL:
First approved in 2021
Source:
BLA125685
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
Oncopig Cancer Model by Sus Clinicals, Inc
(2021)
Source URL:
First approved in 2021
Source:
Oncopig Cancer Model by Sus Clinicals, Inc
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2021)
Source URL:
First approved in 2021
Source:
21 CFR 348
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2023)
Source URL:
First approved in 2021
Source:
21 CFR 348
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
OssaPig-NF-NF1(NS) Miniature Swine by Recombinetics, Inc.
(2021)
Source URL:
First approved in 2021
Source:
OssaPig-NF-NF1(NS) Miniature Swine by Recombinetics, Inc.
Source URL:
Class:
STRUCTURALLY DIVERSE